AVXL
Anavex Life Sciences Corp
NASDAQ: AVXL · HEALTHCARE · BIOTECHNOLOGY
$1.19
-8.46% today
Updated 2026-10-30
Market cap
$115.87M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.14
Dividend yield
—
52W range
$1 – $10
Volume
1.1M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.3
Quality
C+3.0
Profitability
D5.0
Valuation
C+2/9
Piotroski F-Score
Weak
0.8
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →247 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Piotroski 2/9 — weak financial health
- Altman Z 0.83 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-13.54M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-47.98M | $-47.49M | $-43.00M | $-46.38M | $-3.19M |
| EPS | — | — | — | — | $-0.14 |
| Free cash flow | $-24.24M | $-27.79M | $-30.81M | $-39.04M | $-13.54M |
| Profit margin | — | — | — | — | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-01-06 | MISSLING, CHRISTOPHER U | Buy | 125,000 | — |
| 2026-01-06 | BOENISCH, SANDRA | Buy | 12,500 | — |
| 2025-10-02 | MISSLING, CHRISTOPHER U | Buy | 125,000 | — |
Peer comparison
Smart narrative
Anavex Life Sciences Corp trades at $1.19. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 0.83, it sits in the distress.
Frequently asked questions
What is Anavex Life Sciences Corp's stock price?
Anavex Life Sciences Corp (AVXL) trades at $1.19.
Is Anavex Life Sciences Corp overvalued?
Anavex Life Sciences Corp carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
Altman Z-Score?
Anavex Life Sciences Corp's Altman Z-Score is 0.83, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-31.55%
Beta1.17
50D MA$2.54
200D MA$3.24
Shares out0.09B
Float0.09B
Short ratio—
Avg volume1.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—